BIOMAT Database Logo BIOMAT Database Logo

Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of end-inspiratory pause. 1998

E Mouloudi, and K Katsanoulas, and M Anastasaki, and E Askitopoulou, and D Georgopoulos
Intensive Care Unit, University Hospital of Heraklion, University of Crete, Greece.

The delivery of bronchodilators with a metered-dose inhaler (MDI) and a spacer in mechanically ventilated patients has become widespread practice. However, the various ventilator settings that influence the efficacy of MDI are not well established. Application of an end-inspiratory pause (EIP) during drug delivery has been suggested as one of the factors that might increase the effectiveness of this therapy. To test this, the effect of EIP on the bronchodilation induced by beta2-agonists administered with MDI and a spacer in a group of mechanically ventilated patients with chronic obstructive pulmonary disease (COPD) was examined. Twelve patients with COPD, mechanically ventilated on volume-controlled mode, were prospectively randomized to receive six puffs of salbutamol (100 microg x puff(-1)) either with or without EIP of 5 s duration. Salbutamol was administered with an MDI adapted to the inspiratory limb of the ventilator circuit using an aerosol cloud-enhancer spacer. After a 6 h wash-out, patients were crossed over to receive salbutamol by the alternative mode of administration. Static and dynamic airway pressures, minimum (Rmin) and maximum (Rmax) airflow resistance, the difference between Rmax and Rmin (deltaR), static end-inspiratory respiratory system compliance (Cst,rs) and cardiac frequency (fc) were measured before and at 15, 30 and 60 min after salbutamol administration. Salbutamol caused a significant decrease in dynamic and static airway pressures, Rmin and Rmax. These changes were not influenced by application of EIP and were evident at 15, 30 and 60 min after salbutamol. With and without EIP, Cst,rs,deltaR and fc did not change after salbutamol. In conclusion, salbutamol delivered with a metered-dose inhaler and a spacer device induced significant bronchodilation in mechanically ventilated patients with chronic obstructive pulmonary disease, the magnitude of which was not affected by an end-expiratory pause of 5 s. These results do not support the use of end-inspiratory pause when bronchodilators are administered in adequate doses during controlled mechanical ventilation.

UI MeSH Term Description Entries
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009330 Nebulizers and Vaporizers Devices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments. Atomizers,Inhalation Devices,Inhalators,Inhalers,Vaporizers,Nebulizers,Vaporizers and Nebulizers,Atomizer,Device, Inhalation,Devices, Inhalation,Inhalation Device,Inhalator,Inhaler,Nebulizer,Vaporizer
D012121 Respiration, Artificial Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2). Ventilation, Mechanical,Mechanical Ventilation,Artificial Respiration,Artificial Respirations,Mechanical Ventilations,Respirations, Artificial,Ventilations, Mechanical
D012123 Pulmonary Ventilation The total volume of gas inspired or expired per unit of time, usually measured in liters per minute. Respiratory Airflow,Ventilation Tests,Ventilation, Pulmonary,Expiratory Airflow,Airflow, Expiratory,Airflow, Respiratory,Test, Ventilation,Tests, Ventilation,Ventilation Test
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E Mouloudi, and K Katsanoulas, and M Anastasaki, and E Askitopoulou, and D Georgopoulos
Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of flow pattern.
August 2000, The European respiratory journal,
E Mouloudi, and K Katsanoulas, and M Anastasaki, and E Askitopoulou, and D Georgopoulos
Bronchodilator delivery with metered-dose inhalers in mechanically-ventilated patients.
March 1996, The European respiratory journal,
E Mouloudi, and K Katsanoulas, and M Anastasaki, and E Askitopoulou, and D Georgopoulos
Metered dose inhalers for bronchodilator delivery in intubated, mechanically ventilated patients.
January 1991, Chest,
E Mouloudi, and K Katsanoulas, and M Anastasaki, and E Askitopoulou, and D Georgopoulos
A comparison of bronchodilator therapy delivered by nebulization and metered-dose inhaler in mechanically ventilated patients.
June 1999, Chest,
E Mouloudi, and K Katsanoulas, and M Anastasaki, and E Askitopoulou, and D Georgopoulos
Duration of salbutamol-induced bronchodilation delivered by metered-dose inhaler in mechanically ventilated COPD patients.
June 2001, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace,
E Mouloudi, and K Katsanoulas, and M Anastasaki, and E Askitopoulou, and D Georgopoulos
Bronchodilator delivery by metered-dose inhaler in ventilator-supported patients.
June 1995, American journal of respiratory and critical care medicine,
E Mouloudi, and K Katsanoulas, and M Anastasaki, and E Askitopoulou, and D Georgopoulos
Albuterol delivery by metered-dose inhaler in a mechanically ventilated pediatric lung model.
May 1996, Critical care medicine,
E Mouloudi, and K Katsanoulas, and M Anastasaki, and E Askitopoulou, and D Georgopoulos
Metered-dose inhaler versus nebulized albuterol in mechanically ventilated patients.
December 1993, The American review of respiratory disease,
E Mouloudi, and K Katsanoulas, and M Anastasaki, and E Askitopoulou, and D Georgopoulos
Treatment of bronchospasm by metered-dose inhaler albuterol in mechanically ventilated patients.
January 1995, Chest,
E Mouloudi, and K Katsanoulas, and M Anastasaki, and E Askitopoulou, and D Georgopoulos
Effect of end-inspiratory pause duration on plateau pressure in mechanically ventilated patients.
January 2003, Intensive care medicine,
Copied contents to your clipboard!